Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 43 of 79

  1. The aim of this study was to establish and validate a clinical prediction model for assessing the risk of metastasis and patient survival in Ewing's sarcoma (ES).

    Authors: Wenle Li, Shengtao Dong, Yuewei Lin, Huitao Wu, Mengfei Chen, Chuan Qin, Kelin Li, JunYan Zhang, Zhi-Ri Tang, Haosheng Wang, Kang Huo, Xiangtao Xie, Zhaohui Hu, Sirui Kuang and Chengliang Yin
    Citation: BMC Cancer 2022 22:914
  2. Hepatocellular carcinoma (HCC) remains the most frequent liver cancer, accounting for approximately 90% of primary liver cancers worldwide. The recurrence-free survival (RFS) of HCC patients is a critical fact...

    Authors: Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li and Quqin Lu
    Citation: BMC Cancer 2021 21:6
  3. Melanoma-intrinsic activated β-catenin pathway, the product of the catenin beta 1 (CTNNB1) gene, has been associated with low/absent tumor-infiltrating lymphocytes, accelerated tumor growth, metastases developmen...

    Authors: Georgia Sofia Karachaliou, Rached Alkallas, Sarah B. Carroll, Chongshan Caressi, Danny Zakria, Nirali M. Patel, Dimitri G. Trembath, Jennifer A. Ezzell, Guillaume J. Pegna, Paul B. Googe, Jonathan P. Galeotti, Fatih Ayvali, Frances A. Collichio, Carrie B. Lee, David W. Ollila, Margaret L. Gulley…
    Citation: BMC Cancer 2022 22:38
  4. The positive response and the clinical usefulness of 14 serum antibodies in patients with esophageal squamous cell carcinoma (ESCC) were examined in this study. The Cancer Genome Atlas (TCGA) was used to inves...

    Authors: Isamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, Hisashi Gunji, Fumitaka Ishige, Yosuke Iwatate, Akiko Kuwajima, Fumiaki Shiratori, Rei Okada and Hideaki Shimada
    Citation: BMC Cancer 2020 20:1007
  5. Esophageal squamous cell carcinoma (ESCC) survival is mainly reported at the time of treatment. Conditional survival is another prognostic tool to evaluate ESCC patients who has survived more than one year sin...

    Authors: Mingqiang Liang, Jiazhou Xiao, Maohui Chen, Bin Zheng and Chun Chen
    Citation: BMC Cancer 2022 22:333
  6. Glioblastoma (GBM) is a relatively prevalent primary tumor of the central nervous system in children, characterized by its high malignancy and mortality rates, along with the intricate challenges of achieving ...

    Authors: Gen Li, Liya Ma, Chenxi Feng, Hongli Yin, Jianping Bao, Di Wu, Zimu Zhang, Xiaolu Li, Zhiheng Li, Chun Yang, Hairong Wang, Fang Fang, Xiaohan Hu, Mei Li, Lixiao Xu, Yunyun Xu…
    Citation: BMC Cancer 2024 24:220
  7. Cytokeratin 7 (CK7) and GATA binding protein 3 (GATA3) are considered as immunohistochemical hallmarks of breast cancers; however, there are breast tumors lacking these markers. Clinicopathological characteriz...

    Authors: Shaolei Lu, Evgeny Yakirevich, Li Juan Wang, Murray B. Resnick and Yihong Wang
    Citation: BMC Cancer 2019 19:1085
  8. The receptor CXCR4 and its ligand CXCL12 play crucial roles in breast cancer. Despite the fact that the spontaneous feline mammary carcinoma (FMC) is considered a suitable model for breast cancer studies, the ...

    Authors: Cláudia S. Marques, Ana Rita Santos, Andreia Gameiro, Jorge Correia and Fernando Ferreira
    Citation: BMC Cancer 2018 18:741
  9. There is strong evidence that disease progression, drug response and overall clinical outcomes of CML disease are not only decided by BCR/ABL1 oncoprotein but depend on accumulation of additional genetic and e...

    Authors: Sameer Ahmad Guru, Mamta Pervin Sumi, Rashid Mir, Mirza Masroor Ali Beg, Bidhan Chandra koner and Alpana Saxena
    Citation: BMC Cancer 2022 22:405

    The Correction to this article has been published in BMC Cancer 2022 22:439

  10. The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for...

    Authors: Divya Khaitan, Umesh T Sankpal, Babette Weksler, Edward A Meister, Ignacio A Romero, Pierre-Olivier Couraud and Nagendra S Ningaraj
    Citation: BMC Cancer 2009 9:258
  11. Vascular endothelial growth factor (VEGF) is a potent angiogenic cytokine produced physiologically by the uterus. Pathological secretion by tumours promotes growth and metastasis. High circulating VEGF levels ...

    Authors: Aoife J Lowery, Karl J Sweeney, Alan P Molloy, Emer Hennessy, Catherine Curran and Michael J Kerin
    Citation: BMC Cancer 2008 8:279
  12. Targeted therapies are emerging treatment options for gastric cancer (GC). Patient-derived tumor xenograft(PDX) models of GC closely retain the features of the original clinical cancer, offering a powerful too...

    Authors: Haiyong Wang, Jun Lu, Jian Tang, Shitu Chen, Kuifeng He, Xiaoxia Jiang, Weiqin Jiang and Lisong Teng
    Citation: BMC Cancer 2017 17:191
  13. Insulin-like growth factors (IGF´s) play a crucial role in controlling cancer cell proliferation, differentiation and apoptosis. Exercise has been postulated as an effective intervention in improving cancer-re...

    Authors: José Francisco Meneses-Echávez, Emilio González Jiménez, Jacqueline Schmidt Río-Valle, Jorge Enrique Correa-Bautista, Mikel Izquierdo and Robinson Ramírez-Vélez
    Citation: BMC Cancer 2016 16:682
  14. The aims of this study focusing on Locoregionally advanced nasopharyngeal carcinoma (LANPC) were mainly two-fold: on the one hand, to establish a cut-off value to differentiate early and late failure based on ...

    Authors: Xing-Li Yang, Lu-Lu Zhang, Jia Kou, Guan-Qun Zhou, Chen-Fei Wu, Ying Sun and Li Lin
    Citation: BMC Cancer 2022 22:1230
  15. Angiogenesis is important both in normal tissue function and disease and represents a key target in lung cancer (LC) therapy. Unfortunately, the two main subtypes of non-small-cell lung cancers (NSCLC) namely,...

    Authors: J. Rapp, E. Kiss, M. Meggyes, E. Szabo-Meleg, D. Feller, G. Smuk, T. Laszlo, V. Sarosi, T. F. Molnar, K. Kvell and J. E. Pongracz
    Citation: BMC Cancer 2016 16:915
  16. As hybrid RNAs, transcription-induced chimeras (TICs) may have tumor-promoting properties, and some specific chimeras have become important diagnostic markers and therapeutic targets for cancer.

    Authors: Ye Tao, Neil Gross, Xiaojiao Fan, Jianming Yang, Maikun Teng, Xu Li, Guojun Li, Yang Zhang and Zhigang Huang
    Citation: BMC Cancer 2018 18:248
  17. Aberrant chromatin structure in cancer cells results from altered proteins involved in its packaging. Heterochromatin protein 1 gamma (HP1γ) is a non-histone heterochromatic protein that functions to maintain ...

    Authors: Jon Slezak, Matthew Truong, Wei Huang and David Jarrard
    Citation: BMC Cancer 2013 13:148
  18. Repeat radiation is a rarely used treatment strategy that must be performed with caution. The efficacy and toxicity of a second curative radiotherapy series was investigated in cases of recurrent breast cancer.

    Authors: Arndt-Christian Müller, Franziska Eckert, Vanessa Heinrich, Michael Bamberg, Sara Brucker and Thomas Hehr
    Citation: BMC Cancer 2011 11:197
  19. Metastasis is the major cause of death in breast cancers. MMPs play a key role in tumor microenvironment that facilitates metastasis. The existing researches suggest that the high expression of gelatinase A an...

    Authors: Shimin Pei, Xu Yang, Huanan Wang, Hong Zhang, Bin Zhou, Di Zhang and Degui Lin
    Citation: BMC Cancer 2015 15:965
  20. C-reactive protein (CRP) and Serum amyloid A protein (SAA) increases with systemic inflammation and are related to worse survival for breast cancer survivors. This study examines the association between percen...

    Authors: Anne Dee, Roberta McKean-Cowdin, Marian L Neuhouser, Cornelia Ulrich, Richard N Baumgartner, Anne McTiernan, Kathy Baumgartner, Catherine M Alfano, Rachel Ballard-Barbash and Leslie Bernstein
    Citation: BMC Cancer 2012 12:343
  21. Except for overall survival, whether or not waiting time for treatment could influences other domains of cancer patients’ overall well-being is to a large extent unknown. Therefore, we performed this study to ...

    Authors: Huan Song, Fang Fang, Unnur Valdimarsdóttir, Donghao Lu, Therese M.-L. Andersson, Christina Hultman, Weimin Ye, Lars Lundell, Jan Johansson, Magnus Nilsson and Mats Lindblad
    Citation: BMC Cancer 2017 17:2
  22. Long non-coding RNA (lncRNA) plays a critical role in the malignant progression of intrahepatic cholangiocarcinoma (iCCA). This study aimed to establish a 4-lncRNA prognostic signature and explore correspondin...

    Authors: Wenbo Zou, Zizheng Wang, Fei Wang, Lincheng Li, Rong Liu and Minggen Hu
    Citation: BMC Cancer 2021 21:608
  23. Hepatocellular carcinoma (HCC) is considered one of the most common cancers, characterized by low early detection and high mortality rates, and is a global health challenge. Immunogenic cell death (ICD) is def...

    Authors: Cai-Feng Lin, Zhi-Wen Chen, Feng-Ping Kang, Jian-Fei Hu, Long Huang, Cheng-Yu Liao, Jian-Lin Lai, Yi Huang, Zu-Wei Wang, Yi-Feng Tian and Shi Chen
    Citation: BMC Cancer 2023 23:522
  24. Role of biomarkers for promotion of tumor proliferation (BPTPs) and for promotion of apoptosis (BPAs) in thymic malignant tumors is still unclear. The purpose of this study was to evaluate the relationship bet...

    Authors: Huilan Zeng, Weilin Yang, Bo Xu, Jianyong Zou, Chunhua Su, Beilong Zhong, Haoshuai Zhu and Zhenguang Chen
    Citation: BMC Cancer 2020 20:928
  25. Angiogenesis plays an important role in the development and progression of tumors. Kallistatin exerts anti-angiogenic and anti-inflammatory activities that may be effective in inhibiting tumor metastasis. We i...

    Authors: Ai-Li Shiau, Min-Li Teo, Shin-Yao Chen, Chrong-Reen Wang, Jeng-Long Hsieh, Meng-Ya Chang, Chih-Jui Chang, Julie Chao, Lee Chao, Chao-Liang Wu and Che-Hsin Lee
    Citation: BMC Cancer 2010 10:245
  26. There are large ethnic differences in cervical cancer survival in New Zealand that are only partly explained by stage at diagnosis. We investigated the association of comorbidity with cervical cancer survival,...

    Authors: Naomi Brewer, Barry Borman, Diana Sarfati, Mona Jeffreys, Steven T Fleming, Soo Cheng and Neil Pearce
    Citation: BMC Cancer 2011 11:132
  27. Cachexia may occur in 40% of cancer patients, representing the major cause of death in more than 20% of them. The aim of this study was to investigate the role of leptin, ghrelin and obestatin as diagnostic an...

    Authors: Patrizia Mondello, Antonio Lacquaniti, Stefania Mondello, Davide Bolignano, Vincenzo Pitini, Carmela Aloisi and Michele Buemi
    Citation: BMC Cancer 2014 14:828
  28. To investigate the global expression profile of miRNAs, their impact on cellular signaling pathways, and their association with poor prognostic parameters in African-American (AA) patients with triple negative...

    Authors: Safaa Turkistani, Bruna M. Sugita, Paolo Fadda, Rafael Marchi, Ali Afsari, Tammey Naab, Victor Apprey, Robert L. Copeland Jr, Michael C. Campbell, Luciane R. Cavalli and Yasmine Kanaan
    Citation: BMC Cancer 2021 21:861
  29. The C-reactive protein to albumin ratio (CAR) is associated with poor prognosis in various cancers. However, its value in thymic epithelial tumors remains to be elucidated, we aimed to evaluate the prognostic ...

    Authors: Yang-Yu Huang, Xuan Liu, Shen-Hua Liang, Yu Hu and Guo-Wei Ma
    Citation: BMC Cancer 2022 22:1183
  30. Germ cell tumours (GCTs) represent a highly curable malignity as they respond well to cisplatin (CDDP)-based chemotherapy. Nevertheless, a small proportion of GCT patients relapse or do not respond to therapy....

    Authors: Zuzana Cierna, Vera Miskovska, Jan Roska, Dana Jurkovicova, Lucia Borszekova Pulzova, Zuzana Sestakova, Lenka Hurbanova, Katarina Machalekova, Michal Chovanec, Katarina Rejlekova, Daniela Svetlovska, Katarina Kalavska, Karol Kajo, Pavel Babal, Jozef Mardiak, Thomas A. Ward…
    Citation: BMC Cancer 2020 20:17
  31. No widely used prognostic tool exists to demonstrate the benefit of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) in patients with advanced hepatocellular carcinoma (HCC). We aimed to establish a progno...

    Authors: Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak and Arunee Dechaphunkul
    Citation: BMC Cancer 2024 24:281
  32. Overexpression of Cullin7 is associated with some types of malignancies. However, the part of Cullin7 in hepatocellular carcinoma remains unclear. The aim of this study was to investigate the role of Cullin7 i...

    Authors: Jun An, Zhigang Zhang, Zhiyong Liu, Ruizhi Wang, Dayang Hui and Yi Jin
    Citation: BMC Cancer 2017 17:828
  33. The primary aim of treatment of a patient who has developed metastatic disease is palliation. The objectives of the current study are to describe and quantify the clinical management of women with metastatic b...

    Authors: Klaartje Manders, Lonneke V van de Poll-Franse, Geert-Jan Creemers, Gerard Vreugdenhil, Maurice JC van der Sangen, Grard AP Nieuwenhuijzen, Rudi MH Roumen and Adri C Voogd
    Citation: BMC Cancer 2006 6:179
  34. The activity of the epidermal growth factor receptor (EGFR)-directed monoclonal antibody cetuximab combined with oxaliplatin/leucovorin/5-fluorouracil (FUFOX) was assessed in first-line metastatic gastric and ...

    Authors: Birgit Luber, Joëlle Deplazes, Gisela Keller, Axel Walch, Sandra Rauser, Martin Eichmann, Rupert Langer, Heinz Höfler, Susanna Hegewisch-Becker, Gunnar Folprecht, Ewald Wöll, Thomas Decker, Esther Endlicher, Sylvie Lorenzen, Falko Fend, Christian Peschel…
    Citation: BMC Cancer 2011 11:509
  35. Breast cancer in Tunisia is often diagnosed at a late stage with long delay in time to consultation and to diagnosis.The aim of this study is to estimate the sensitivity and specificity of the transcutaneous b...

    Authors: Imtinene Belaid, Mohamed Fedy Baya, Saif Ben Ayed, Ali Ben Ayed, Jihen Maatoug, Nawel Zommit, Mohamed Anas Trabelsi, Noureddine Ben Chida, Hedi Khairi, Leila Ben Fatma, Imene Chabchoub, Nouha Ammar, Rym Bourigua, Makrem Hochlaf, Faten Ezzaari and Slim Ben Ahmed
    Citation: BMC Cancer 2024 24:151
  36. Gastric cancer (GC) accounts for the fourth most occurring malignancy and the third major cause of cancer death. Identifying novel molecular signaling pathways participating in gastric tumorigenesis and progre...

    Authors: Jianxin Ye, Jinsheng Huang, Jie Xu, Qiang Huang, Jinzhou Wang, Wenjing Zhong, Xinjian Lin, Yun Li and Xu Lin
    Citation: BMC Cancer 2017 17:626
  37. This study aimed to identify metabolic subtypes in ESCA, explore their relationship with immune landscapes, and establish a metabolic index for accurate prognosis assessment.

    Authors: Xiao-wan Yu, Pei-wei She, Fang-chuan Chen, Ya-yu Chen, Shuang Zhou, Xi-min Wang, Xiao-rong Lin, Qiao-ling Liu, Zhi-jun Huang and Yu Qiu
    Citation: BMC Cancer 2024 24:230
  38. Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma (CTCL) that transforms from mature, skin-homing T cells and progresses during the early stages in the skin. The role of the skin microenvironment i...

    Authors: Syed Jafar Mehdi, Andrea Moerman-Herzog and Henry K. Wong
    Citation: BMC Cancer 2021 21:492
  39. Glucose regulated proteins (GRPs) are main regulators of cellular homeostasis due to their role as molecular chaperones. Moreover, the functions of GRPs suggest that they also may play important roles in cance...

    Authors: Rupert Langer, Marcus Feith, Joerg Rüdiger Siewert, Hans-Juergen Wester and Heinz Hoefler
    Citation: BMC Cancer 2008 8:70
  40. Increasing interest has been devoted to the expression and possible role of sex hormone receptors in gastric cancer, but most of these findings are controversial. In the present study, the expression profile o...

    Authors: Lu Gan, Jian He, Xia Zhang, Yong-Jie Zhang, Guan-Zhen Yu, Ying Chen, Jun Pan, Jie-Jun Wang and Xi Wang
    Citation: BMC Cancer 2012 12:566
  41. Breast cancer patients often have a poor prognosis largely due to lack of effective targeted therapy. It is now well established that monosaccharide enhances growth retardation and chemotherapy sensitivity in ...

    Authors: Shilong Yu, Zhaoyi Yue and Qilun Liu
    Citation: BMC Cancer 2024 24:639
  42. This study aims to develop a nomogram integrating inflammation (NLR), Prognostic Nutritional Index (PNI), and EBV DNA (tumor burden) to achieve personalized treatment and prediction for stage IVA NPC. Furtherm...

    Authors: Yuhui pan, Zihan Chen, Wenquan Hong, Zongwei Huang, Ying Li, Sunqin Cai, Jinghua Lai, Jun Lu and Sufang Qiu
    Citation: BMC Cancer 2024 24:578
  43. Interrogation of site-specific CpG methylation in circulating tumor DNAs (ctDNAs) has been employed in a number of studies for early detection of breast cancer (BrCa). In many of these studies, the markers wer...

    Authors: Manny D. Bacolod, Jianmin Huang, Sarah F. Giardina, Philip B. Feinberg, Aashiq H. Mirza, Alexander Swistel, Steven A. Soper and Francis Barany
    Citation: BMC Cancer 2020 20:85
  44. Sarcopenia has been identified as a potential negative prognostic factor in cancer patients. In this study, our objective was to investigate the relationship between the assessment method for sarcopenia using ...

    Authors: Katsuya Sakamoto, Shin-ichiro Hiraoka, Kohei Kawamura, Peiying Ruan, Shuji Uchida, Ryo Akiyama, Chonho Lee, Kazuki Ide and Susumu Tanaka
    Citation: BMC Cancer 2024 24:128
  45. We reported previously the usefulness of 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to predict prognosis of renal cell carcinoma (RCC) treated with molecular targ...

    Authors: Tadashi Tabei, Noboru Nakaigawa, Tomohiro Kaneta, Ichiro Ikeda, Keiichi Kondo, Kazuhide Makiyama, Hisashi Hasumi, Narihiko Hayashi, Takashi Kawahara, Koji Izumi, Kimito Osaka, Kentaro Muraoka, Jun-ichi Teranishi, Yasuhide Miyoshi, Yasushi Yumura, Hiroji Uemura…
    Citation: BMC Cancer 2019 19:298

Featured videos

View featured videos from across the BMC-series journals